389030 Stock Chart & Stats
$1910.00
-$110.00(-5.45%)
―
--
Day’s Range― - ―
52-Week Range$1,610.00 - $6,480.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)289.81K
Market Cap
₩79.57B
Enterprise Value$67.92K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Nov 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-215.00
Shares Outstanding39,392,270
10 Day Avg. Volume454,121
30 Day Avg. Volume289,813
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
389030 FAQ
What was GENINUS, Inc.’s price range in the past 12 months?
GENINUS, Inc. lowest stock price was $1610.00 and its highest was $6480.00 in the past 12 months.
What is GENINUS, Inc.’s market cap?
GENINUS, Inc.’s market cap is ₩79.57B.
When is GENINUS, Inc.’s upcoming earnings report date?
GENINUS, Inc.’s upcoming earnings report date is Nov 13, 2026 which is in 63 days.
How were GENINUS, Inc.’s earnings last quarter?
GENINUS, Inc. released its earnings results on Aug 14, 2026. The company reported -$215 earnings per share for the quarter.
Is GENINUS, Inc. overvalued?
According to Wall Street analysts GENINUS, Inc.’s price is currently Undervalued.
Does GENINUS, Inc. pay dividends?
GENINUS, Inc. does not currently pay dividends.
What is GENINUS, Inc.’s EPS estimate?
GENINUS, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GENINUS, Inc. have?
GENINUS, Inc. has 39,392,270 shares outstanding.
What happened to GENINUS, Inc.’s price movement after its last earnings report?
GENINUS, Inc. reported an EPS of -$215 in its last earnings report. Following the earnings report the stock price went down -4.526%.
Which hedge fund is a major shareholder of GENINUS, Inc.?
Currently, no hedge funds are holding shares in KR:389030
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
Osang Healthcare Co. Ltd.
―
Cellumed Co., Ltd.
―
Choong Ang Vaccine Laboratory
―
Enzychem Lifesciences Corp.
―
Xiilab Co., Ltd.
―